Related Experiment Video
Updated: May 18, 2026

08:35
Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
The relationship between tissue oxygenation and redox status using magnetic resonance imaging
Fuminori Hyodo1, Ryan M Davis, Emi Hyodo
1Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
International Journal of Oncology
|September 26, 2012
Summary
A new bi-modality magnetic resonance imaging/electron paramagnetic resonance imaging (MRI/EPRI) platform reveals that a more reduced tumor microenvironment correlates with increased tumor hypoxia. This finding suggests Tempol decay rate can indicate tumor oxygenation status.
Area of Science:
- Biomedical Imaging
- Cancer Research
- Biophysics
Background:
- Longitudinal monitoring of tumor oxygenation and redox status is crucial for understanding cancer progression.
- Bi-modality magnetic resonance imaging/electron paramagnetic resonance imaging (MRI/EPRI) offers a novel approach for in vivo assessment.
Purpose of the Study:
- To test the hypothesis that a more reducing tumor microenvironment accompanies tumor hypoxia.
- To evaluate the utility of a bi-modality MRI/EPRI platform for assessing tumor characteristics.
Main Methods:
- Utilized a bi-modality MRI/EPRI platform in murine cancer models (SCCVII tumors).
- Measured tumor redox status using Tempol (MRI contrast agent) and tumor hypoxia using Oxo63 (EPRI spin probe).
- Acquired images longitudinally to track changes in pO(2) and Tempol reduction rates.
Main Results:
- Median tumor pO(2) decreased from 14 mmHg to 7 mmHg between 7 and 15 days post-implantation.
- The hypoxic fraction (pO(2)<10 mmHg) increased from 10% to 60% with tumor growth.
- Tempol reduction rate increased with tumor volume, correlating with decreased oxygenation.
Conclusions:
- A more reducing tumor microenvironment is associated with developing tumor hypoxia.
- The Tempol decay rate constant shows potential as a surrogate marker for tumor hypoxia.
- The bi-modality MRI/EPRI platform enables effective longitudinal monitoring of tumor oxygenation and redox status.

